[ CrossRef ] [ Google scholar ] [ PubMed ] Bobyntsev II, Chernysheva OI, Dolgintsev ME, Smakhtin M, Belykh AE
The drug prescribed for weight loss purposes for adults who have a high body mass index (BMI) and may benefit from losing weight, regardless of whether they have diabetes or not
Nat Rev Microbiol 16(3):156170 Hallett RL et al (2004) Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes
Same molecules, different biology None of these price differences change the compound class doing the work: GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the dual agonist tirzepatide, evidenced by STEP ( NEJM , 2021), SURMOUNT ( NEJM , 2022), and SURMOUNT-OSA ( NEJM , 2024)